BU-NOT-SET

Recipharm’s ambition is to promote an entrepreneurial spirit, local accountability and a common management model across its global teams. 

Recipharm has developed a number of internal governance documents designed to support the highest management standards across the business, including its Policies, Code of Conduct and Internal Control Standards. 

The company’s sustainability indicators are monitored regularly, and each of Recipharm’s operating companies is responsible for reporting status on them. Oversight is carried out at Group level with direct feedback to the CEO and the Board.

 

Sustainability policies

Recipharm has a strong drive to deliver on our sustainability commitments demonstrating our intent to be a responsible and sustainable company. We achieve this through our vision, business strategy, and global policies.

Our Global Environmental and Climate Policy, and our Global Health and Safety Policy provides an overview of the matters identified in Recipharm’s materiality analysis. Local policies should include the same topics, but also add potential local material topics. The global environmental and climate policy is part of our global documentation system, and is approved by our CEO.

The purpose of these policies is also to meet any external requirements and expectations that Recipharm has committed to adhere to. We achieve this through our vision, business strategy, and global policies. Please see the full documents below.

 

Environmental and climate policy

 

Health and safety policy

Whistleblowing system – Speak up!

Everyone is encouraged to speak up and report potential compliance violations involving Recipharm. Both Recipharm employees and Recipharm associated third parties can report compliance misconduct. Reports can be made anonymously, but anonymity may limit the ability to run an investigation fully and thoroughly.  

Recipharm employees and Recipharm associated third parties can use the Recipharm whistleblowing system, operated by a third-party service provider: 

  • by phone +46 77 177 99 77 (Swedish or English language only) or 
  • via online form (in all Recipharm sites’ languages) Recipharm associated third parties shall use the code kng483. 

Recipharm does not tolerate any retaliation against anyone who raises a compliance concern in good faith. 

Recipharm handles any report of potential compliance violations with the highest ethical standards. 
 

Tax strategy

This document sets out the tax strategy for Roar HoldCo AB and its subsidiaries (the “Group”), as required under the United Kingdom legislation referring to paragraph 19(2) Schedule 19 of Finance Act 2016, United Kingdom. This tax strategy applies to the year ending 31 December 2024 and continues until superseded. It covers the Group’s approach to arranging its tax affairs.

 

Download here

Materiality and stakeholder dialogue

Stakeholder dialogue
Recipharm has identified employees, customers, owners, and suppliers as key stakeholders. We are introducing a more ongoing and structured dialogue with all relevant stakeholders regarding important business topics, including sustainability. There is also ongoing dialogue regarding the sustainability requirements from our owners and how Recipharm performs according to these.

Materiality assessment
Areas, which were refined along with long-term goals in 2022. 
In 2024, we are conducting a double materiality assessment according to the upcoming EU Corporate Sustainability Reporting Directive (CSRD).